C12N 2760/18133
Use of viral protein as therapeutic agent other than vaccine
Official title: Use of viral protein as therapeutic agent other than vaccine, e.g. apoptosis inducing or anti-inflammatory
C12N2760/18133 (Use of viral protein as therapeutic agent other than vaccine) appears on 7 US grants and 11 published applications in this corpus.
Search patents in C12N- Granted patents
- 7
- Published applications
- 11
- Assignees
- 6
- Inventors
- 25
- Latest grant
- 6 Jan 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 1 |
| 2015 | 0 | 0 |
| 2016 | 0 | 2 |
| 2017 | 0 | 0 |
| 2018 | 0 | 3 |
| 2019 | 2 | 0 |
| 2020 | 0 | 2 |
| 2021 | 0 | 0 |
| 2022 | 2 | 1 |
| 2023 | 0 | 1 |
| 2024 | 1 | 0 |
| 2025 | 0 | 1 |
| 2026 | 1 | 0 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Recombinant herpesvirus of turkeys (HVT) and preparation method and use thereof6 Jan 2026US 12,516,353 B2Yangzhou University
- Newcastle disease viruses and uses thereof23 Jul 2024US 12,042,534 B2Icahn School of Medicine at Mount Sinai
- Oncolytic virus for treating brain tumors using recombinant Newcastle disease virus into which Newcastle disease virus vector-based PTEN gene is inserted and composition for treating brain tumors using same20 Dec 2022US 11,530,422 B2Libentech Co., Ltd.
- Compositions featuring an attenuated newcastle disease virus and methods of use for treating neoplasia18 Oct 2022US 11,471,499 B2MedImmune, LLC
- Compositions featuring an attenuated Newcastle disease virus and methods of use for treating neoplasia31 Dec 2019US 10,519,426 B2MedImmune, LLC
- Newcastle disease viruses and uses thereof24 Apr 2025US 2025/0127879 A1Icahn School of Medicine at Mount Sinai
- Recombinant herpesvirus of turkeys (hvt) and preparation method and use thereof11 May 2023US 2023/0147673 A1Yangzhou University
- Oncolytic virus for treating brain tumors using recombinant newcastle disease virus into which newcastle disease virus vector-based pten gene is inserted and composition for treating brain tumors using same17 Nov 2022US 2022/0364112 A1Libentech Co., Ltd.
- Compositions featuring an attenuated newcastle disease virus and methods of use for treating neoplasia11 Jun 2020US 2020/0181581 A1MedImmune, LLC
- Newcastle disease viruses and uses thereof27 Feb 2020US 2020/0061184 A1Icahn School of Medicine at Mount Sinai
Most cited
By later US patents
- Virus-modified tumor vaccines for immunotherapy of tumor metastases19US 5,273,745 A1993
- Newcastle disease viruses and uses thereof4US 10,251,922 B2Icahn School of Medicine at Mount Sinai · 2019
- Compositions featuring an attenuated Newcastle disease virus and methods of use for treating neoplasia3US 10,519,426 B2MedImmune, LLC · 2019
- Newcastle disease viruses and uses thereof1US 12,042,534 B2Icahn School of Medicine at Mount Sinai · 2024